The Vanguard Group 13D and 13G filings for Editas Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 2:30 pm Unchanged |
2024-09-30 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 6,679,450 8.090% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:57 am Sale |
2024-09-30 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 6,679,450 8.090% |
-1,782,251 (-21.06%) |
Filing |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 8,461,701 10.360% |
1,588,578 (+23.11%) |
Filing |
| 2023-02-09 11:16 am Sale |
2022-12-30 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 6,873,123 10.000% |
-454,919 (-6.21%) |
Filing |
| 2022-03-09 08:44 am Purchase |
2022-02-28 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 7,328,042 10.690% |
654,145 (+9.80%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 6,673,897 9.760% |
849,011 (+14.58%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Editas Medicine, Inc. EDIT |
The Vanguard Group | 5,824,886 9.340% |
1,257,270 (+27.53%) |
Filing |